PYXS 8-K 2026-09-09

Pyxis Oncology, Inc. (PYXS) 8-K dated 2026-09-09 — accession 0001193125-26-385901. This URL is the filing, not the PYXS hub.

Pyxis Oncology, Inc. (PYXS) is a biotechnology company listed on NASDAQ.

Pyxis Oncology, Inc. filed a 8-K on 2026-09-09. Accession 0001193125-26-385901.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.

Not investment advice. The PYXS SEC hub lists recent forms. The stock page is the research view.